Friday 6 November 2026 Export TXG’s income statement to Excel — free account

10x Genomics

TXG Healthcare Medical Devices

10x Genomics' revenue for fiscal 2025 (year ended December 2025) was $642.8 million, up 5.25% from fiscal 2024.

Revenue: +1.12%
EPS: +31.8%
Free cash flow: −4.61%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

59.18 1.12 +1.93%

Follow TXG

Alert me

Market cap: $7.6B
P/E: 0.0×
Fwd P/E: −95.9×
Dividend yield: —
F-score: 6/9
Altman Z: 3.99
Beneish M: −3.23
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 6 Nov
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		3.17	4.26	8.08	19.11
P/FCF ratio Full definition →		15.76	22.48	41.38	127.41
P/Operating CF Full definition →		49.90	104.27	293.60	746.52
P/B ratio Full definition →		2.56	3.34	6.04	14.10
Price to Tangible BV Full definition →		2.79	3.63	6.58	15.30
EV/Sales Full definition →		2.40	3.47	7.23	18.23
EV/EBITDA Full definition →		0.00	314.06	0.00	0.00
EV/Operating CF Full definition →		11.33	17.32	35.10	113.07
EV/FCF Full definition →		11.93	18.27	37.04	121.52
Quick Ratio Full definition →		3.95	5.25	5.09	4.10
Current Ratio Full definition →		4.46	5.90	5.69	5.12
Net Debt/EBITDA Full definition →		63.41	76.15	93.22	0.00
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.66	0.67	0.61	0.59
Operating CF/Net income Full definition →		(2.51)	(1.94)	(0.95)	(0.82)
Capex/Depreciation Full definition →		(0.16)	(0.16)	(0.12)	0.00
Research and Development Expense of Revenue Full definition →		33.71%	37.69%	37.60%	35.13%
Selling, General and Administrative Expense of Revenue Full definition →		46.15%	44.00%	52.08%	50.48%
Intangible Assets out of Total Assets Full definition →		0.06	0.06	0.07	0.06
Share Based Compensation of Revenue Full definition →		15.19%	15.01%	16.96%	15.33%
Graham Net Nets Full definition →		0.22	0.17	0.09	0.04
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(2.15%)	(0.80%)	(1.54%)	(0.58%)
Free Cash Flow Yield Full definition →		6.35%	4.45%	2.42%	0.78%
Revenue per Share Full definition →		1.33	1.18	1.16	1.15
Operating CF per Share Full definition →		0.33	0.20	0.13	0.12
Capex per Share Full definition →		(0.01)	(0.01)	(0.01)	(0.01)
Free Cash Flow per Share Full definition →		0.31	0.19	0.12	0.11
Cash per Share Full definition →		4.20	4.21	4.25	4.40
Shareholders Equity per Share Full definition →		6.38	6.35	6.35	6.41
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		6.38	6.35	6.35	6.41
Free Cash Flow Full definition →		39.00	24.52	15.39	14.86
Working Capital Full definition →		531.00	556.14	556.16	578.26
Capital Expenditures Full definition →		(1.78)	(1.60)	(1.59)	(0.97)
Net Current Asset Value Full definition →		439.41	468.30	470.15	493.54
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.01	0.01	0.01	0.01
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		85.48	54.34	84.85	—
Average Payables Full definition →		12.82	13.75	18.32	19.83
Average Inventory Full definition →		69.72	64.10	60.79	63.29
Average Assets Full definition →		980.00	959.58	1,005.02	1,045.25
Average Common Equity Full definition →		753.23	760.61	799.41	811.58

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly